Showing 1 - 10 of 5,756
In response to increasing health expenditures and a high number of physician visits, the German government introduced a copayment for ambulatory care in 2004 for individuals with statutory health insurance (SHI). Because persons with private insurance were exempt from the copayments, this health...
Persistent link: https://www.econbiz.de/10003726009
Persistent link: https://www.econbiz.de/10003918273
Persistent link: https://www.econbiz.de/10003978870
In response to increasing health expenditures and a high number of physician visits, the German government introduced a copayment for ambulatory care in 2004 for individuals with statutory health insurance (SHI). Because persons with private insurance were exempt from the copayments, this...
Persistent link: https://www.econbiz.de/10009663837
Persistent link: https://www.econbiz.de/10003087395
In response to increasing health expenditures and a high number of physician visits, the German government introduced a copayment for ambulatory care in 2004 for individuals with statutory health insurance (SHI). Because persons with private insurance were exempt from the copayments, this health...
Persistent link: https://www.econbiz.de/10011632066
In response to increasing health expenditures and a high number of physician visits, the German government introduced a copayment for ambulatory care in 2004 for individuals with statutory health insurance (SHI). Because persons with private insurance were exempt from the copayments, this health...
Persistent link: https://www.econbiz.de/10014218988
In response to increasing health expenditures and a high number of physician visits, the German government introduced a copayment for ambulatory care in 2004 for individuals with statutory health insurance (SHI). Because persons with private insurance were exempt from the copayments, this health...
Persistent link: https://www.econbiz.de/10014218994
Die steigenden Ausgaben im Gesundheitswesen führten in den letzten Jahren zu einer Vielzahl von Kostensenkungsmaßnahmen. Anhand von standardisierten Befragungen untersucht Verena Reichl die Folgen für Ärzte, Patienten und die pharmazeutische und medizintechnische Industrie. Die statistischen...
Persistent link: https://www.econbiz.de/10014017363